LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2021. For the first quarter of 2021, worldwide sales from continuing operations were $247.6 million, an increase of 2.1 percent on a reported basis and a decline of 0.4 […]
Financial
GEN inCode Announces Major UK Collaboration With Royal Brompton and Harefield Hospitals
OXFORD, England, April 28, 2021 /PRNewswire/ — GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces today a collaboration with Royal Brompton and Harefield hospitals (“RB&H”), recently merged with Guy’s and St Thomas’ NHS Foundation Trust (“GSTT”), to provide globally leading cardiovascular disease clinical genetic […]
Boston Scientific Announces Results For First Quarter 2021
MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.752 billion during the first quarter of 2021. This represents growth of 8.2 percent on a reported basis, 5.6 percent on an operational1 basis and 5.9 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP […]
Mentice publishes the company’s interim report for the period January-March 2021
STOCKHOLM, April 28, 2021 /PRNewswire/ — Strongest order intake in Mentice’s history despite the corona pandemic First quarter (January-March 2021) Order intake amounted to 39.9 (32.5) MSEK. Order book by end of the period was 72.9 (33.9) MSEK. Net sales amounted to 32.3 (33.8) MSEK. Operating income for the period before depreciations (EBITDA) […]
Quantum Genomics Secures €3 Million Non-dilutive Financing
€1.5 million guaranteed by the French government (PGE) and granted by BNP bank €1.5 million innovation and R&D loan granted by Bpifrance Funding will allow for acceleration of R&D programs PARIS, April 28, 2021 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the […]
Dr. Paula A. Johnson Joins Abiomed Board of Directors
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ:ABMD) announces the appointment of Paula A. Johnson, MD, MPH, to the Abiomed Board of Directors, effective immediately. Dr. Johnson will serve as a member of the Governance and Nominating Committee of the board. Following the appointment of Dr. Johnson, the board now comprises nine active directors. “Dr. […]
CHF Solutions Expands Commercial Focus, Changes Name to Nuwellis
The new name reflects the company’s commitment to pediatric, critical care, and chronic heart failure patients EDEN PRAIRIE, Minn., April 27, 2021 (GLOBE NEWSWIRE) — Company names are reflective of the services provided to its customers, and CHF Solutions – a leader and pioneer in the heart failure space – […]
James R. Tobin, Former CEO of Boston Scientific, Joins Xenter, Inc. Board of Directors to Assist in Advance of Device/Data/Drug Technologies
-Xenter’s next-generation technology advances interventional medicine by integrating functions that formerly required multiple devices- SALT LAKE CITY–(BUSINESS WIRE)–On the heels of its April 7 launch announcement, Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced that James R. Tobin has been appointed to the company’s Board of Directors. Founded […]
BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates
Second Biotherapeutic Partnership of 2021 SAN CARLOS, Calif., April 26, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], today announced that it has entered into an agreement with a leading Japanese biotechnology company related to BioCardia Helix catheter biotherapeutic delivery product candidates. Under the terms of the agreement, BioCardia will receive $500,000, […]
Vector Raises $12.5 Million in Series A Funding to Accelerate the Adoption of Digital Health and Remote Care in Cardiology
Aging Baby Boomer Population and Urgent Need During Pandemic Fuels Rapid Growth for Remote Cardiac Monitoring BEND, Ore.–(BUSINESS WIRE)–Vector Remote Care, a pioneering cardiac digital health provider, today announced it has closed a $12.5 million Series A investment led by Updata Partners. The funding will be used to accelerate product, […]
Recent
Late-Breaking Data from PRESERVE Trial Evaluates XVIVO’s HOPE Preservation Approach in Heart Transplantation
APPLE WATCH CAPTURES MORE PEDIATRIC ARRHYTHMIA EVENTS THAN TRADITIONAL PATCH MONITORS
FLEX Vascular Announces 12-Month Real-World Outcomes Demonstrating Strong Safety, Durability, and Reduced Reinterventions with FLEX™ Vessel Prep System
Popular
- No commented posts yet